Abstract
A 31-year-old woman with primary infertility presented to our hospital for management. She had initially been investigated 5 years earlier for primary amenorrhea, where a high follicle-stimulating hormone level (55 mIU/mL), a low 17β-estradiol level (12.9 pg/mL), a low antimüllerian hormone (0.02 ng/mL) level, and normal levels of testosterone, prolactin, and thyroid-stimulating hormone were reported. Her karyotype was 46, XX and she had been commenced on hormone replacement therapy with estrogen and progestin that resulted in withdrawal bleeds.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
